It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
An extreme thermophilic bacterium, Thermus thermophilus produces more than 20 unusual polyamines, but their biosynthetic pathways, including homospermidine, are not yet fully understood. Two types of homospermidine synthases have been identified in plants and bacteria, which use spermidine and putrescine or two molecules of putrescine as substrates. However, homospermidine synthases with such substrate specificity have not been identified in T. thermophilus. Here we identified a novel agmatine homocoupling enzyme that is involved in homospermidine biosynthesis in T. thermophilus. The reaction mechanism is different from that of a previously described homospermidine synthase, and involves conjugation of two molecules of agmatine, which produces a diamidino derivative of homospermidine (caldomycin) as an immediate precursor of homospermidine. We conclude that there is a homospermidine biosynthetic pathway from agmatine via caldomycin synthase followed by ureohydrolase in T. thermophilus. Furthermore, it is shown that caldomycin is a novel compound existing in nature.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Chiba Institute of Science, Faculty of Pharmacy, Choshi, Japan (GRID:grid.443455.7) (ISNI:0000 0004 1793 0095)
2 Chiba Institute of Science, Faculty of Pharmacy, Choshi, Japan (GRID:grid.443455.7) (ISNI:0000 0004 1793 0095); Hoshi University School of Pharmacy and Pharmaceutical Sciences, Department of Pathophysiology and Therapeutics, Shinagawa, Japan (GRID:grid.412239.f) (ISNI:0000 0004 1770 141X)
3 RIKEN Center for Biosystems Dynamics Research (BDR), Tsurumi, Japan (GRID:grid.508743.d)
4 Amine Pharma Research Institute, Innovation Plaza at Chiba University, Chiba, Japan (GRID:grid.452325.7)
5 Josai University, Faculty of Pharmacy and Pharmaceutical Sciences, Sakado, Japan (GRID:grid.411949.0) (ISNI:0000 0004 1770 2033)
6 Institute of Environmental Biology, Kyowa-Kako, Machida, Japan (GRID:grid.410823.c)
7 Chiba Institute of Science, Faculty of Pharmacy, Choshi, Japan (GRID:grid.443455.7) (ISNI:0000 0004 1793 0095); International University of Health and Welfare, School of Pharmacy, Otawara, Japan (GRID:grid.411731.1) (ISNI:0000 0004 0531 3030)




